Daniel Blaney-Koen, JD, is a senior legislative attorney with the American Medical Association Advocacy Resource Center (ARC). The ARC attorneys focus on working with state and specialty medical societies on state legislative, regulatory and policy advocacy. In addition to his work in the ARC, Blaney-Koen has held several roles at the AMA, including serving as a public information officer, policy analyst and speechwriter. Currently, he focuses on state legislation and policy concerning the nation’s opioid epidemic, with particular emphasis on overdose prevention and treatment. He also covers other pharmaceutical issues as well as insurance market reforms. Prior to joining the AMA in 1999, Blaney-Koen earned his Master of Fine Arts in Poetry from Colorado State University, and his bachelor's degree from the University of Arizona. He earned his law degree from the Loyola University Chicago School of Law. Blaney-Koen, his wife, two young sons and daughter live in Chicago.

 

Dr. Campopiano is senior medical adviser of the Center for Substance Abuse Treatment which is part of the Substance Abuse and Mental Health Services Administration. Her activities have included development of SAMHSA’s Opioid Overdose Prevention Toolkit, Brief Guides on Medication for the Treatment of Alcohol Use Disorder and the Clinical Use of Extended-Release Injectable Naltrexone in the treatment of Opioid Use Disorder, and the recent Advisory: Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder. She served as chairperson for the Treatment and Recovery Committee of the National Heroin Taskforce in 2015.

 

Originally from Iowa, Dr. Campopiano is a graduate of the University of Pittsburgh School of Medicine. She is board certified in Family Medicine and Addiction Medicine. She provided primary care and buprenorphine services in her solo practice in Pittsburgh and was medical director of Western Psychiatric Institute and Clinic’s Opioid Addiction Treatment Program prior to coming to SAMHSA.

Dr. Kelly Clark has focused her career on issues of addictive disease, evidence informed behavioral health care, and payment reform.  She is Chief Medical Officer of CleanSlate Centers, a multi-state medical group currently treating over 6,000 opioid addicted patients with medication management which has received a SAMHSA Science to Service Award for Office Based Opioid Treatment and a Center of Excellence Award from the Commonwealth of Pennsylvania.   She is active on the Association of Managed Care Pharmacy’s Addiction Treatment Advisory Group and as a member of the American Psychiatric Associations Integration Work Group; served on the writing committee of the Johns Hopkins Bloomberg School of Public Health’s recent policy document, “The Prescription Drug Epidemic: An Evidence Based Approach” ; as expert to the National Safety Council, the United States Comptroller General, and the US Attorney General’s office in Kentucky, where she is past president of the Kentucky Society of Addiction Medicine; and led the workgroup on Health Systems and Reimbursement at SAMHSA’s Buprenorphine Summit.   Dr. Clark earned an MBA from The Fuqua School of Business at Duke University and her medical degree from the University of Wisconsin.  She continues her work as a founding member of the Advisory Board of the National Rx Drug Abuse and Heroin Summit.

Following 34 years as a teacher, career counselor, and administrative coordinator, Nancy Hale retired from public education in 2012 and joined Operation UNITE (Unlawful Narcotics Investigations, Treatment and Education) as Co-Program Director for the UNITE Service Corps (AmeriCorps) Program.  In February 2015, she was named UNITE’s third President & CEO.

 

Very involved in her community, Ms. Hale has served as an Executive Board Member and volunteer with the Rockcastle County (KY) UNITE Coalition for the last 11 years, with the Kentucky YMCA Youth Association for 26 years, as well as a current Board Member and twice-elected President of the Kentucky Association of Professional Educators.

 

As a member of the Delta Kappa Gamma Society, Pi Chapter, Ms. Hale was named "Kentucky Volunteer of the Year" four times (1998, 1999, 2000 and 2004). She received the "Golden Apple Achiever Award" from Ashland Oil, Inc. in 2000 as one of Kentucky's outstanding educators. In 2001, she was chosen as the "Kentucky YMCA Champion," and was the first inductee into the Kentucky YMCA Youth Advisor Hall of Fame in 2010.

 

She and her husband, John, also an educator and principal for 43 years, are the parents of two grown sons and have two granddaughters.

 

David Hamby was appointed National Coordinator, National Emerging Threats Initiative (NETI) in January 2017. Before his current appointment, he was the Deputy Coordinator of NETI, previously known as the National Methamphetamine and Pharmaceuticals Initiative (NMPI)/Atlanta-Carolinas HIDTA. A member of the National HIDTA program since March 2008, Mr. Hamby serves as principle emerging threats advisor to the HIDTA program as well as State and local entities. He oversees specialized training, current trends, analytical support, best practices, innovative programs, and strategic planning for the program’s national approach to combat emerging drug threats. Mr. Hamby retired from the Hamilton County Sheriff’s Office in Chattanooga Tennessee as Captain after a distinguished 30-year career in law enforcement, serving 18 years in the field of narcotics enforcement. Mr. Hamby served five years as Director of the SE Tennessee Methamphetamine Task Force. He has received numerous awards and citations, including the Appreciation Award as Project Coordinator in the aftermath of Hurricane Katrina for Critical Incidence Stress Debriefing (CISD) for law enforcement officers in the State of Mississippi.

 

Christopher M. Jones currently serves as the Director of the National Mental Health and Substance Use Policy Laboratory at the Substance Abuse and Mental Health Services Administration (SAMHSA). Prior to joining SAMHSA, Dr. Jones served as Acting Associate Deputy Assistant Secretary for Science and Data Policy and Director of the Division of Science Policy in the Office of the Assistant Secretary for Planning and Evaluation (ASPE) at the U.S. Department of Health and Human Services.  The Office of Science and Data Policy is the HHS focal point for policy research, analysis, evaluation, and coordination of public health, science, and data policy activities, and provides authoritative advice and analytical support to HHS leadership on public health, science, and data policy issues and initiatives.  He has also served as senior advisor in the Office of the Commissioner at the U.S. Food and Drug Administration (FDA) and led the Centers for Disease Control and Prevention’s (CDC) drug abuse and overdose activities where he focused on strategic policy development and implementation, engaging national and state partners, and conducting research to improve policy and clinical practice.  During his career, Dr. Jones has served as Senior Public Health Advisor to the White House Office of National Drug Control Policy, led the FDA’s Drug Safety and Risk Communication team, and served on the Science Team in the CDC’s Strategic National Stockpile.  He received his Bachelor of Science degree from Reinhart College, his Doctor of Pharmacy degree from Mercer University, his Master of Public Health degree from New York Medical College, and is currently completing his Doctorate of Public Health in Heath Policy at The George Washington University Milken Institute School of Public Health.  Dr. Jones has authored more than 50 peer-reviewed publications on the topic of drug abuse and overdose.

J. Kevin Massey is the Health Administrator for Correct Care Solutions, which is a leading, national provider of correctional health services in the United States. He leads an integrated clinical team of more than 100 professionals who deliver inpatient dental, medical, mental health and nursing; serving over 1,300 patients located at the New Orleans Jail and Hunt Mental Health Facility. Previously, Massey was the Director of Strategic Business Development and Clinical Innovation for the Weitzman Institute at the Community Health Center, Inc., which provides outpatient primary care serving over 150,000 underserved patients and tests promising innovations in primary care delivery. He has served as the Director of Injury Prevention for the State of Delaware, Department of Health, responsible for engaging state and national leaders, to improve health policy, clinical practice and executing broad-based prevention/population health programs. Prior leadership roles include: Chief Operating Officer at the Kent Community Health Center, a $20M outpatient primary care health center, and Interim Director of Marketing/Community Engagement for United Healthcare, Delaware Medicaid Managed Care Plan. Massey has served on the National Rx Drug Abuse & Heroin Summit Advisory Board since 2013, and he has co-published and presents at Rx and heroin abuse conferences nationwide.

Cece Spitznas, PhD, is Senior Science Policy Advisor in the Office of National Drug Control Policy (ONDCP), a component of the Executive Office of the President. She provides policy analysis and scientific advice to the ONDCP Director and Chief of Staff on special matters of concern to ONDCP, such as emerging drug trends and demand reduction, and helps to develop legislative responses to problems of national scope, particularly on Rx drugs, heroin and fentanyl. In 2012, she organized a National Leadership Meeting for ONDCP on Maternal Substance Use and Neonatal Abstinence Syndrome. From 2000-2012, Spitznas was a program official at the National Institute on Drug Abuse (NIDA), where her research portfolio concerned developing and testing new screening, brief interventions and treatments for people with substance use disorders, including pregnant women, and developing provider training. She received her clinical and research training in psychology at the University of New Mexico and the University of Alabama at Birmingham (UAB) School of Medicine. She worked as a research professor at UAB, conducting research on relapse and treatment for crack cocaine use in homeless cocaine users prior to joining the NIH.

Judge David A. Tapp serves as a Circuit Judge in the 28th Judicial Circuit of the Kentucky Court of Justice, a position which he has held for twelve years. He previously served as a limited jurisdiction judge. 
Judge Tapp has devoted a substantial portion of judicial career to the development of effective substance abuse and community treatment programs.  

 

In 2015, the National Association of Drug Court Professionals (NADCP) awarded Judge Tapp’s drug court with the Community Transformation Award, one of only fifteen drug courts to receive the honor out of over 2,500 treatment courts worldwide.  In 2011, he received the All Rise award from the NADCP for his efforts involving funding issues for substance abuse courts. In addition, Judge Tapp is responsible for Kentucky’s successful implementation of a high-risk probation supervision program modeled on Hawaii’s HOPE probation and was responsible for implementing Kentucky’s first use of medically assisted treatment within the Commonwealth’s drug courts.

   
Currently, Judge Tapp serves as the Chairperson of Kentucky’s Circuit Judges Education Committee and in that capacity is responsible for the education of all general jurisdiction and family court judges. Until 2017, Judge Tapp served as Co-Chairperson of the Judicial Child Fatality Task Force which focused on the safety of children within the judicial and child protective system. He also currently serves as a member of the Governor’s Criminal Justice Policy Assessment Council and the U.S. Coordinating Council for Juvenile Justice and Delinquency Prevention. Judge Tapp is a frequent speaker and author on a wide variety of justice related issues and formerly an adjunct professor at the University of Louisville Brandeis School of Law.

Judge Tapp received his J.D. in 1993 from the University of Louisville Brandeis School of Law, a M.S. in Criminal Justice Administration from Chaminade University of Honolulu in 1991, and a B.A. from Morehead State University in 1983.